Fig. 4
From: Efficacy and safety of azvudine versus nirmatrelvir/ritonavir in cancer patients with COVID-19
Kaplan‒Meier curves of composite disease progression among cancer patients with COVID-19 receiving azvudine and Paxlovid.
Fig. 4 | Scientific Reports
